NEW YORK, July 14, 2016 /PRNewswire/ -- Cardiac Markers provides market assessment, estimate and competitive analysis for tests for cardiovascular disease (CVD) that use biomarkers, including:
- Worldwide Cardiovascular Disease Biomarkers Diagnostic Market 2015 and 2020
- Selected IVD Markers of Cardiovascular Disease
- Selected Biomarkers and Biomarker Panels for Cardiovascular Disease, and Companies Developing/Marketing These Biomarkers
- Selected Lipid Biomarkers, and Companies Developing/Marketing These Biomarkers
Biomarkers are biological or biochemical molecules, or genetic changes, or other characteristics that can be measured, and that indicate or predict a condition, risk, or likely response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. With the incidence of cardiovascular disease increasing greatly, cardiac markers are in huge demand.
Physicians use cardiac markers (CK-MB, troponin I, troponin T, myoglobin, brain natriuretic peptide (BNP), proBNP, high sensitive C-reactive protein (hsCRP), and homocysteine) and cardiovascular biomarkers in two ways: acute care to diagnose a cardiac event in a hospital emergency room (acute care) or chronic care to evaluate the risk of a cardiovascular event occurring and to monitor patients with a cardiovascular disease. The traditional markers CK-MB, troponin and myoglobin were used in acute care and tests such as cholesterol were used to evaluate risk.
Cardiac Markers reviews the progression of cardiac diagnostic technologies and notes some trends in test strategies as well, including cardiac risk, genetics and cardiovascular disease, acute myocardial infarction and acute coronary syndrome, heart failure, lipid disorders, and ACP coronary heart disease screening.
There are currently a number of companies developing or marketing cardiac markers and cardiovascular biomarkers. This report contains profiles of many of the top competitors, including: - Abbott Laboratories
- Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
- bioMerieux SA
- Quest Diagnostics
- Roche Diagnostics
- Siemens Healthcare Diagnostics
Read the full report: http://www.reportlinker.com/p03971221-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cardiac-markers-300298984.html